Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sage Therapeutics

6.68
+0.08351.27%
Volume:356.99K
Turnover:2.36M
Market Cap:418.53M
PE:-1.15
High:6.72
Open:6.52
Low:6.44
Close:6.60
Loading ...

VirExit Technologies Secures Reseller Agreement with SAGE

TIPRANKS
·
16 May

J.P. Morgan Keeps Their Hold Rating on SAGE Therapeutics (SAGE)

TIPRANKS
·
07 May

SAGE Therapeutics (SAGE) Gets a Hold from Truist Financial

TIPRANKS
·
05 May

Tetra Tech to Acquire SAGE Group Holdings

MT Newswires Live
·
01 May

Nasdaq-listed engineering services giant swoops on Adelaide’s SAGE

The Australian Financial Review
·
01 May

Tetra Tech to Advance Its Digital Automation Solutions with the Acquisition of SAGE Group

Business Wire
·
01 May

Sage Therapeutics’ Earnings Call Highlights Growth and Uncertainty

TIPRANKS
·
01 May

Q1 2025 SAGE Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
30 Apr

Sage Therapeutics Inc (SAGE) Q1 2025 Earnings Call Highlights: Strong Demand for ZURZUVAE and ...

GuruFocus.com
·
30 Apr

Cautious Hold Rating on SAGE Therapeutics Amid Financial Pressures and Strategic Uncertainties

TIPRANKS
·
30 Apr

SAGE Therapeutics (SAGE) Gets a Hold from Mizuho Securities

TIPRANKS
·
30 Apr

Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Misses Revenue Estimates

Zacks
·
30 Apr

SAGE Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
30 Apr

Sage Therapeutics Q1 EPS USD -1.01

THOMSON REUTERS
·
30 Apr

Sage Therapeutics Q1 EPS $(1.01) Misses $(0.99) Estimate, Sales $14.06M Inline

Benzinga
·
30 Apr

Sage Therapeutics Inc: Strategic Alternatives Review Process Remains Ongoing

THOMSON REUTERS
·
30 Apr

Sage Therapeutics Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates

THOMSON REUTERS
·
30 Apr

Sage Therapeutics- Cash Runway Expected to Support Operations to Mid-2027

THOMSON REUTERS
·
30 Apr

Sage Therapeutics Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates

Business Wire
·
30 Apr

SAGE Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview

Reuters
·
26 Apr